Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MYCOPHENOLATE MOFETIL, with a corresponding US DMF Number 22046.
Remarkably, this DMF maintains an Active status since its submission on October 02, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 03, 2019, and payment made on June 14, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II